Development of chimeric antigen receptors targeting T-cell malignancies using two structurally different anti-CD5 antigen binding domains in NK and CRISPR-edited T cell lines-Reference-Cited by-同舟云学术

Development of chimeric antigen receptors targeting T-cell malignancies using two structurally different anti-CD5 antigen binding domains in NK and CRISPR-edited T cell lines

Published:2017-12-26 Issue:3 Volume:7 Page:e1407898
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Raikar Sunil S.¹^ORCID,Fleischer Lauren C.¹²^ORCID,Moot Robert¹²,Fedanov Andrew¹,Paik Na Yoon¹,Knight Kristopher A.¹,Doering Christopher B.¹²,Spencer H. Trent¹²

Affiliation:

1. Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia

2. Department of Molecular and Systems Pharmacology, Graduate Division of Biological and Biomedical Sciences, Emory University School of Medicine, Atlanta, Georgia

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2017.1407898

Reference69 articles.

1. T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial

2. Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia

3. Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia

4. Chimeric Antigen Receptor T Cell Therapy Targeting CD19-Positive Leukemia and Lymphoma in the Context of Stem Cell Transplantation

5. A T-cell–directed chimeric antigen receptor for the selective treatment of T-cell malignancies

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic potentials of adoptive cell therapy in immune-mediated neuropathy;Journal of Autoimmunity;2024-12

2. T cell receptor-directed antibody-drug conjugates for the treatment of T cell-derived cancers;Molecular Therapy: Oncology;2024-09

3. Advances in CAR-T-cell therapy in T-cell malignancies;Journal of Hematology & Oncology;2024-06-24

4. CRISPR/Cas9: Role of genome editing in cancer immunotherapy;Oral Oncology Reports;2024-06

5. Chimeric antigen receptor T-cell therapy for T-cell acute lymphoblastic leukemia;Haematologica;2024-05-10